Immunic to participate in industry and scientific conferences in july

New york , june 28, 2022 /prnewswire/ -- immunic , inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced participation in the following industry and scientific conferences in july: july 5-6: 3rd forum science & health: medicine of the future. members of immunic's management and communications teams will attend this conference in fÜrstenfeldbruck near munich, germany.
IMUX Ratings Summary
IMUX Quant Ranking